On this episode of MedTech Smarts with Rita, Anna Crooke, Rita King, and Shavini Fernando dive into the realities of bringing a medical device to market. Drawing on Shavini’s journey with OxiWear, a pioneering pulse oximeter, the conversation explores the hurdles of FDA submissions, the pressure of investor expectations, and why early collaboration is critical. The discussion highlights how transparency, strategic planning, and strong partnerships between founders, investors, and regulatory experts are essential to turning innovation into lasting success in the medical device industry.

This week on MedTech Smarts with Rita, the panel tackles today’s toughest funding challenges in MedTech, from shrinking venture capital to limited grants and the impact on commercialization timelines. Special guest Nikin Shah reveals how creative lending and strategic partnerships offer fresh pathways for growth, while experts Rita and Richard share actionable insights for leveraging regulatory planning as a business asset. The episode spotlights tools like LuminLogic, showing how robust compliance systems can boost investor confidence and accelerate execution. Whether you're a founder or investor, this discussion delivers strategies for navigating the capital crunch and building scalable, resilient MedTech companies.

This week on MedTech Smarts with Rita, we're launching a special mini-series called "Before You Build It: Lessons from 25 Years of MedTech Startups." We'll dive into the realities of building a medical device startup from securing funding to navigating FDA clearance. Join industry veterans Rita King and Richard Holcomb as they unpack what most founders wish they'd known early on so they could get it right from the very beginning.

On this episode of MedTech Smarts with Rita, MethodSense founder and CEO Rita King joins Anna Crooke to take a closer look at one of the most talked about advancements at the FDA: their new artificial intelligence tool, Elsa. Anna and Rita break down what Elsa means for MedTech executives, why it’s making waves in the industry, and how this tool could shape the future of medical device regulation.